Skip to main content
Skip to main navigation
Invalid credentials.
Search for :
Product Development Strategy
Early Clinical Development
Phase I/IIa Clinical Trials
Phase II/III Clinical Trials
Interventional Phase IIIb/Phase IV Clinical Trials
Observational Research & Registries
Product Launch & Management
Market Access Solutions
Strategic Sales Outsourcing
Biopharmaceutical R&D
Biopharmaceutical Sales & Marketing
Biosimilars
Healthcare Payers & Providers
Medical Device & Diagnostics
Public Health & Government
Cardiovascular
Central Nervous System
Diabetes & Endocrinology
Infectious Diseases
Internal Medicine
Oncology
Early Phase Oncology
Translational Oncology
Pediatrics
Public Health Interest
Vaccines
Other Therapeutic Areas
Our Focus
Our Values
Our Heritage
Our Leadership
Ethics & Compliance
Investors
Quintiles Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research
RESEARCH TRIANGLE PARK, NC – May 21, 2013 – Quintiles is the industry leader that best differentiates itself on service quality in Phase II/III clinical research, according to 157 pharmaceutical and biotechnology professionals who responded to Industry Standard Research’s (ISR) 2013 CRO Quality Benchmarking Report – Phase II/III.
Read Press ReleaseView All Press Releases
Get updates on News, Events, Presentations and Broadcasts sent to via text or your personal email. You can also subscribe to our podcasts on iTunes to hear the latest broadcasts.
Allscripts and Quintiles Partner to Develop Software Solutions for Clinical and Post-Approval Research
AGREEMENT EXPANDS QUINTILES CAPABILITIES TO SUPPORT DRUG APPROVALS IN JAPAN
The work we do with the biopharmaceutical industry, payers and providers has a profound effect on extending patients’ lives and quality of life around the world. Learn More About Quintiles